Why the study?
Does FFR discriminate between suboptimally and optimally deployed stents in an in vitro model?
Does FFR discriminate between suboptimally and optimally deployed stents in an in vitro model?
In an in vitro model, FFR was less sensitive than IVUS and QCA for assessing optimal stent deployment due to its high dependence on flow rates.
FFR's limited sensitivity to deployment quality in vitro cautions against sole reliance for optimization; leaves open comparative validation versus IVUS/QCA.
We tested whether fractional flow reserve (FFR) discriminates between suboptimally and optimally deployed stents. Latex tubes (diameter solidus in circle = 4 mm) with diameter stenosis 40% (n = 3), 50% (n = 3) and 60% (n = 3) were tested in a pulsatile flow system, using water. Measurements were done at baseline (n = 9; FFR/QCA) and after suboptimal (SOD; 3-mm balloon at 8 atm) and optimal (OD; 4 mm balloon at 16 atm) deployment of a 35-mm stent (n = 6; FFR/QCA/IVUS). Varying Q from 150 to 50 ml/min increased FFR by 2-7%. Conversely, at 100 ml/min, FFR increased by only 0.8% from SOD to OD (P < 0.05). Extrapolating data to blood flow, the gain in FFR from SOD to OD is less than 5% for Q = 100 ml/min, while FFR may increase by 15-20% by changes in blood flow from 50 to 150 ml/min. We conclude that IVUS and QCA are more appropriate for the assessment of optimal stent deployment.
No takes yet. Share an insight, caveat, or question.
Matthys et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: